CHRONIC GRANULOMATOUS DISEASE (CGD)
Clinical trials for CHRONIC GRANULOMATOUS DISEASE (CGD) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRANULOMATOUS DISEASE (CGD) trials appear
Sign up with your email to follow new studies for CHRONIC GRANULOMATOUS DISEASE (CGD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Time treatment aims to cure devastating immune disorder
⭐️ CURE ⭐️ ENROLLING_BY_INVITATIONThis study is testing a one-time gene therapy for people with X-linked Chronic Granulomatous Disease (X-CGD), a rare genetic disorder that cripples the immune system. Doctors will collect a patient's own blood stem cells, use a virus to insert a healthy copy of the faulty gene, a…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ CURE ⭐️
Last updated Mar 30, 2026 14:32 UTC
-
Groundbreaking Two-Transplant strategy aims to cure devastating immune diseases
⭐️ CURE ⭐️ ENROLLING_BY_INVITATIONThis study is testing a new two-step procedure for people with severe inherited immune system diseases who also have life-threatening lung damage. First, patients receive a double-lung transplant to fix their lungs. Then, they receive a bone marrow transplant from the same donor,…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Phase: PHASE1, PHASE2 • Sponsor: Paul Szabolcs • Aim: ⭐️ CURE ⭐️
Last updated Mar 30, 2026 14:30 UTC